Mark Alvino sold $71k of ABEO
director at ABEONA THERAPEUTICS INC.. 13,500 shares at an average of $5.23, traded Jan 21, 2026, filed Jan 21, 2026.
Score components
- +15RoleDirector
- +8Trade size$71k at market
- +5Share of holdings soldSold 22% of holdings
- +15Cluster9 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -0.9%, 3m +6.0%, 6m +20.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-003094, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 21, 2026 | SOpen-market sale Common Stock | -13,500 | $5.23 | $71k | 48,752 | Jan 21, 2026 |
Related signals
Other insiders at ABEONA THERAPEUTICS INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | ABEONA THERAPEUTICS INC. | Madhav Vasanthavada Chief Commercial Officer | $25k 4,902 shares | -2% | |
| 36Weak | ABEONA THERAPEUTICS INC. | Brendan M. O'Malley SVP, Chief Legal Officer | $35k 6,727 shares | -2% | |
| 43Moderate | ABEONA THERAPEUTICS INC. | Joseph Walter Vazzano Chief Financial Officer | $47k 9,191 shares | -2% | |
| 50Moderate | ABEONA THERAPEUTICS INC. | Vishwas Seshadri Chief Executive Officer | $101k 19,608 shares | -2% | |
| 29Weak | ABEOsell ABEONA THERAPEUTICS INC. | Mark Alvino director | $88k 15,000 shares | -19% | |
| 37Weak | ABEONA THERAPEUTICS INC. | Joseph Walter Vazzano Chief Financial Officer | $9,651 1,478 shares | -0% | |
| 39Weak | ABEONA THERAPEUTICS INC. | Madhav Vasanthavada Chief Commercial Officer | $88k 12,606 shares | -4% | |
| 39Weak | ABEONA THERAPEUTICS INC. | Brendan M. O'Malley SVP, Chief Legal Officer | $84k 12,050 shares | -3% | |
| 57Moderate | ABEONA THERAPEUTICS INC. | Vishwas Seshadri Chief Executive Officer | $473k 67,971 shares | -5% | |
| 48Moderate | ABEONA THERAPEUTICS INC. | Joseph Walter Vazzano Chief Financial Officer | $173k 24,880 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.